HU190699B - Process for producing analgesic composition containing nalbufin - Google Patents

Process for producing analgesic composition containing nalbufin Download PDF

Info

Publication number
HU190699B
HU190699B HU822851A HU285182A HU190699B HU 190699 B HU190699 B HU 190699B HU 822851 A HU822851 A HU 822851A HU 285182 A HU285182 A HU 285182A HU 190699 B HU190699 B HU 190699B
Authority
HU
Hungary
Prior art keywords
nalbuphine
pharmaceutically acceptable
acceptable salt
analgesic
morphine
Prior art date
Application number
HU822851A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael R Magruder
Original Assignee
Michael R Magruder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael R Magruder filed Critical Michael R Magruder
Publication of HU190699B publication Critical patent/HU190699B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU822851A 1981-09-08 1982-09-07 Process for producing analgesic composition containing nalbufin HU190699B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/300,394 US4366159A (en) 1981-09-08 1981-09-08 Nalbuphine-narcotic analgesic composition and method of producing analgesia

Publications (1)

Publication Number Publication Date
HU190699B true HU190699B (en) 1986-10-28

Family

ID=23158917

Family Applications (1)

Application Number Title Priority Date Filing Date
HU822851A HU190699B (en) 1981-09-08 1982-09-07 Process for producing analgesic composition containing nalbufin

Country Status (14)

Country Link
US (1) US4366159A (OSRAM)
EP (1) EP0074105A1 (OSRAM)
JP (1) JPS5855422A (OSRAM)
AR (1) AR228984A1 (OSRAM)
AU (1) AU549070B2 (OSRAM)
CA (1) CA1200501A (OSRAM)
FI (1) FI823112A7 (OSRAM)
GR (1) GR76702B (OSRAM)
HU (1) HU190699B (OSRAM)
IL (1) IL66743A (OSRAM)
NZ (1) NZ201841A (OSRAM)
PH (1) PH18772A (OSRAM)
PT (1) PT75521A (OSRAM)
ZA (1) ZA826500B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477457A (en) * 1982-10-28 1984-10-16 E. I. Du Pont De Nemours And Company Method for inducing anorexia using nalmetrene
US4478840A (en) * 1983-10-11 1984-10-23 E. I. Du Pont De Nemours And Company Appetite suppressing compositions and methods
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US4769372A (en) * 1986-06-18 1988-09-06 The Rockefeller University Method of treating patients suffering from chronic pain or chronic cough
GB8820327D0 (en) * 1988-08-26 1988-09-28 May & Baker Ltd New compositions of matter
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
HU218673B (hu) * 1993-10-07 2000-10-28 Euroceltique S.A. Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
WO2003004033A1 (en) 2001-07-06 2003-01-16 Penwest Pharmaceuticals Company Sustained release formulations of oxymorphone
WO2003004030A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
PT2939696E (pt) 2001-10-18 2016-06-17 Nektar Therapeutics Conjugados poliméricos de antagonistas de opióides
EP2422773A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US7192966B2 (en) * 2002-11-15 2007-03-20 Branded Products For The Future Pharmaceutical composition
AU2003296954A1 (en) * 2002-12-13 2004-07-09 The Regents Of The University Of California Analgesic combination comprising nalbuphine
RS53279B (sr) * 2003-12-16 2014-08-29 Nektar Therapeutics Monodisperzne smeše pegilisanog naloksola
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
ES2636657T3 (es) 2006-06-19 2017-10-06 Alpharma Pharmaceuticals Llc Composición farmacéutica
US20080318994A1 (en) 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
FR2963889B1 (fr) * 2010-08-20 2013-04-12 Debregeas Et Associes Pharma Formulations a base de nalbuphine et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB769517A (en) * 1953-10-20 1957-03-06 Merck & Co Inc Analgesic compositions
US3493657A (en) * 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US3879555A (en) * 1970-11-16 1975-04-22 Bristol Myers Co Method of treating drug addicts
GB1390772A (en) * 1971-05-07 1975-04-16 Endo Lab Oral narcotic composition
US3966940A (en) * 1973-11-09 1976-06-29 Bristol-Myers Company Analgetic compositions
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4282215A (en) * 1980-06-17 1981-08-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof

Also Published As

Publication number Publication date
AR228984A1 (es) 1983-05-13
AU8804282A (en) 1983-03-17
PT75521A (en) 1982-10-01
US4366159A (en) 1982-12-28
PH18772A (en) 1985-09-25
JPS5855422A (ja) 1983-04-01
IL66743A0 (en) 1982-12-31
FI823112L (fi) 1983-03-09
EP0074105A1 (en) 1983-03-16
IL66743A (en) 1986-07-31
AU549070B2 (en) 1986-01-09
ZA826500B (en) 1984-04-25
GR76702B (OSRAM) 1984-08-29
FI823112A0 (fi) 1982-09-08
NZ201841A (en) 1984-12-14
CA1200501A (en) 1986-02-11
FI823112A7 (fi) 1983-03-09

Similar Documents

Publication Publication Date Title
HU190699B (en) Process for producing analgesic composition containing nalbufin
US5834477A (en) Opiate analgesic formulation with improved safety
JP4311369B2 (ja) ４，５−エポキシモルヒナン誘導体を含有する安定な医薬品組成物
JP3115119B2 (ja) トラマドール ｎ−オキシド材料、そのエナンチオマー及び組成物、ならびにその利用
US20040192783A1 (en) Use of B-2 bronchodilator drugs
IE58314B1 (en) Pharmaceutical products providing enhanced analgasia
US6521266B1 (en) Composition for growth hormone production and release, appetite suppression, and methods related thereto
EA006939B1 (ru) Парентеральная композиция парацетамола
CA1120400A (en) Method of treating hypertension and medicaments therefor
EP2366393B1 (en) Roflumilast for the treatment of pulmonary hypertension
JP5100619B2 (ja) ロキソプロフェン含有医薬製剤１
AU689577B2 (en) New combination of a beta -receptor blocker and a local anaesthetic
HU194736B (en) Improved process for production of antiinflammable preparative
IE59327B1 (en) Prazosin-pirbuterol combination for bronchodilation
HU225779B1 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
KR930011994B1 (ko) 파라세타몰의 생체이용율을 높이는 방법 및 이 생체이용율이 높아진 파라세타몰을 함유한 제제
EP1652532A1 (en) Medicinal composition
RU2401831C2 (ru) Средство, снижающее влечение к алкоголю, фармацевтическая композиция и способы ее получения, лекарственное средство и способ лечения
CA2233677C (en) A novel combination of a .beta.-receptor blocker and an opioid
US3836667A (en) Method of producing bronchodilation
US4131681A (en) Antiallergic method
AU604554B2 (en) Treatment of cardiac arrhythmias
IE900537L (en) Anesthetic oral compositions
US20060172979A1 (en) New use of GABAB receptor agonists
JP2545321B2 (ja) 平滑筋収縮抑制剤